The Enterprise Value as of November 2024 (TTM) for GB Sciences, Inc. (GBLX) is 1.79M

According to GB Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79M. This represents a change of -62.96% compared to the average of 4.83M of the last 4 quarters.

GB Sciences, Inc. (GBLX) Historical Enterprise Value (quarterly & annually)

How has GBLX Enterprise Value performed in the past?

The mean historical Enterprise Value of GB Sciences, Inc. over the last ten years is 22.08M. The current 1.79M Enterprise Value has changed 709.92% with respect to the historical average. Over the past ten years (40 quarters), GBLX's Enterprise Value was at its highest in in the December 2017 quarter at 114.17M. The Enterprise Value was at its lowest in in the June 2014 quarter at 1.66M.

GB Sciences, Inc. (GBLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GB Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GB Sciences, Inc. (GBLX) Average Enterprise Value

How has GBLX Enterprise Value performed in the past?

The current Enterprise Value of GB Sciences, Inc. (GBLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GB Sciences, Inc. (GBLX) Enterprise Value vs. Peers

How is GBLX’s Enterprise Value compared to its peers?

GB Sciences, Inc.’s Enterprise Value is less than Biostage, Inc. (57.66M), less than Antibe Therapeutics Inc. (4.67M), less than Awakn Life Sciences Corp. (4.81M), less than Tryp Therapeutics Inc. (7.59M), less than America Great Health (12.38M), less than Theralink Technologies, Inc. (19.38M), less than Adhera Therapeutics, Inc. (0), less than SciSparc Ltd. (10.81M), greater than Cellectis S.A. (540.60K), less than Biotron Limited (115.55M), less than Regenicin, Inc. (16.98M), greater than AXIM Biotechnologies, Inc. (15.35K), less than Bioasis Technologies Inc. (7.01M), greater than MultiCell Technologies, Inc. (397.14K), greater than Health Sciences Group, Inc. (50.10K), less than Wesana Health Holdings Inc. (0), greater than BetterLife Pharma Inc. (336.60K), less than Covalon Technologies Ltd. (0), less than null (14.85M), less than null (93.17M),

Build a custom stock screener for GB Sciences, Inc. (GBLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GB Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GB Sciences, Inc. (GBLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GB Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.